Loading insider details...
Latest Form 4 (Jan 13, 2026): Grant/Award of 25,000 LTRN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 13, 2026 | Lantern Pharma Inc. (LTRN) | Grant/Award | 25,000 | n/a |
| Nov 12, 2025 | Annovis Bio, Inc. (ANVS) | Purchase | 97,561 | $200.0K |
| Jun 5, 2025 | Annovis Bio, Inc. (ANVS) | Grant/Award | 46,000 | $155.0K |
| Jul 17, 2024 | Lantern Pharma Inc. (LTRN) | Grant/Award | 5,000 | n/a |
| Jul 3, 2024 | Annovis Bio, Inc. (ANVS) | Gift | 10,000 | n/a |
| Nov 21, 2023 | Annovis Bio, Inc. (ANVS) | Grant/Award | 41,186 | $250.0K |
| Apr 26, 2023 | Annovis Bio, Inc. (ANVS) | Gift | 3,000 | n/a |
| Apr 12, 2023 | Annovis Bio, Inc. (ANVS) | Grant/Award | 20,000 | $252.2K |
| Feb 8, 2023 | Annovis Bio, Inc. (ANVS) | Exercise/Conversion | 52,755 | $7.4K |
| Jan 20, 2023 | Annovis Bio, Inc. (ANVS) | Grant/Award | 21,312 | n/a |